Form 4 holding
Director
NEOGENOMICS INC
- Security class
- Common Stock
- Shares / value
- 56,967
- Estimated value
- $422,695
- Report date
- 01 Jun 2026
- Price
- $7.42
- Ownership
- Direct
David Brian Perez
Insider Reports History
- Reporting-owner location
- Lakewood, CO
- Latest reporting-owner signature
-
/s/ Ali Olivo, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for David Brian Perez
Form 4 holding
Director
NEOGENOMICS INC
- Security class
- Restricted Stock Unit
- Shares / value
- 12,254
- Estimated value
- $192,878
- Report date
- 01 Jun 2024
- Price
- $15.74
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
NEOGENOMICS INC
- Security class
- Restricted Stock Unit
- Shares / value
- 15,970
- Estimated value
- $108,202
- Report date
- 01 Jun 2026
- Price
- $8.83
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,254
Form 4 holding
Director
NEOGENOMICS INC
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 11,069
- Estimated value
- $76,573
- Report date
- 01 Jun 2026
- Price
- $8.83
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,672
Form 4 holding
Director
NEOGENOMICS INC
- Security class
- Common Stock
- Shares / value
- 10,000
- Estimated value
- $74,200
- Report date
- 01 Jun 2026
- Price
- $7.42
- Ownership
- Perez Joint Revocable Trust David & Karen Perez TTEE U/A Dated 12/09/2016
Form 4 holding
Director
Ortho Clinical Diagnostics Holdings plc
- Security class
- Ordinary Shares, $0.00001 par value
- Shares / value
- 0
- Estimated value
- Report date
- 27 May 2022
- Price
- $18.77
- Ownership
- Direct
Insider Reports Filed by David Brian Perez
4
NEO
NEOGENOMICS INC
- Report period
- 01 Jun 2026
- Transactions
- 4
- Transaction value
- $0
- Accepted by SEC
- 03 Jun 2026, 19:46
- Role
- Director
- Next action
- Open filing details
4
NEO
NEOGENOMICS INC
- Report period
- 01 Jun 2025
- Transactions
- 4
- Transaction value
- $0
- Accepted by SEC
- 03 Jun 2025, 16:06
- Role
- Director
- Next action
- Open filing details
4
NEO
NEOGENOMICS INC
- Report period
- 05 May 2025
- Transactions
- 1
- Transaction value
- +$76,300
- Accepted by SEC
- 07 May 2025, 16:05
- Role
- Director
- Next action
- Open filing details
4
NEO
NEOGENOMICS INC
- Report period
- 10 Aug 2024
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 13 Aug 2024, 16:34
- Role
- Director
- Next action
- Open filing details
4
NEO
NEOGENOMICS INC
- Report period
- 01 Jun 2024
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 04 Jun 2024, 16:09
- Role
- Director
- Next action
- Open filing details
4
NEO
NEOGENOMICS INC
- Report period
- 10 Aug 2023
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 14 Aug 2023, 17:42
- Role
- Director
- Next action
- Open filing details
4
NEO
NEOGENOMICS INC
- Report period
- 03 Nov 2022
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 07 Nov 2022, 16:13
- Role
- Director
- Next action
- Open filing details
3
NEO
NEOGENOMICS INC
- Report period
- 03 Nov 2022
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 07 Nov 2022, 16:11
- Role
- Director
- Next action
- Open filing details
4
Ortho Clinical Diagnostics Holdings plc
- Report period
- 27 May 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 01 Jun 2022, 16:00
- Role
- Director
- Next action
- Open filing details